Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah C Mash

Showing results (61-70 of 142) with videos related to

Pageof 15
Sort By:
Parkinsonism & Related Disorders|December 31, 2016
Determinants of denervation-independent depletion of putamen dopamine in Parkinson's disease and multiple system atrophyDavid S Goldstein, Patti Sullivan, Courtney Holmes, et al.
Elife|October 16, 2018
Species and cell-type properties of classically defined human and rodent neurons and gliaXiao Xu, Elitsa I Stoyanova, Agata E Lemiesz, et al.
Molecular and Cellular Neurosciences|May 26, 2015
Alzheimer disease (AD) specific transcription, DNA methylation and splicing in twenty AD associated lociCrystal Humphries, Martin A Kohli, Patrice Whitehead, et al.
Journal of Neurochemistry|December 21, 2005
Cocaine-induced alterations in nucleus accumbens ionotropic glutamate receptor subunits in human and non-human primatesScott E Hemby, Wenxue Tang, Emil C Muly, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 10, 2003
Cocaine abusers have an overexpression of alpha-synuclein in dopamine neuronsDeborah C Mash, Qinjie Ouyang, John Pablo, et al.
Neurobiology of Aging|October 1, 2011
The neuroprotective enzyme CYP2D6 increases in the brain with age and is lower in Parkinson's disease patientsAmandeep Mann, Sharon L Miksys, Andrea Gaedigk, et al.
Scientific Reports|July 16, 2017
Gene Network Dysregulation in Dorsolateral Prefrontal Cortex Neurons of Humans with Cocaine Use DisorderEfrain A Ribeiro, Joseph R Scarpa, Susanna P Garamszegi, et al.
Archives of Neurology|September 13, 2006
Clinical heterogeneity of the LRRK2 G2019S mutationSpiridon Papapetropoulos, Carlos Singer, Owen A Ross, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 15, 2010
Intronic polymorphisms affecting alternative splicing of human dopamine D2 receptor are associated with cocaine abuseRobert A Moyer, Danxin Wang, Audrey C Papp, et al.
Neuropharmacology|August 26, 2015
Noribogaine is a G-protein biased κ-opioid receptor agonistEmeline L Maillet, Nicolas Milon, Mari D Heghinian, et al.
Pageof 15

Showing results (61-70 of 142) with videos related to

Sort By:
Pageof 15
Parkinsonism & Related Disorders|December 31, 2016
Determinants of denervation-independent depletion of putamen dopamine in Parkinson's disease and multiple system atrophyDavid S Goldstein, Patti Sullivan, Courtney Holmes, et al.
Elife|October 16, 2018
Species and cell-type properties of classically defined human and rodent neurons and gliaXiao Xu, Elitsa I Stoyanova, Agata E Lemiesz, et al.
Molecular and Cellular Neurosciences|May 26, 2015
Alzheimer disease (AD) specific transcription, DNA methylation and splicing in twenty AD associated lociCrystal Humphries, Martin A Kohli, Patrice Whitehead, et al.
Journal of Neurochemistry|December 21, 2005
Cocaine-induced alterations in nucleus accumbens ionotropic glutamate receptor subunits in human and non-human primatesScott E Hemby, Wenxue Tang, Emil C Muly, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 10, 2003
Cocaine abusers have an overexpression of alpha-synuclein in dopamine neuronsDeborah C Mash, Qinjie Ouyang, John Pablo, et al.
Neurobiology of Aging|October 1, 2011
The neuroprotective enzyme CYP2D6 increases in the brain with age and is lower in Parkinson's disease patientsAmandeep Mann, Sharon L Miksys, Andrea Gaedigk, et al.
Scientific Reports|July 16, 2017
Gene Network Dysregulation in Dorsolateral Prefrontal Cortex Neurons of Humans with Cocaine Use DisorderEfrain A Ribeiro, Joseph R Scarpa, Susanna P Garamszegi, et al.
Archives of Neurology|September 13, 2006
Clinical heterogeneity of the LRRK2 G2019S mutationSpiridon Papapetropoulos, Carlos Singer, Owen A Ross, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 15, 2010
Intronic polymorphisms affecting alternative splicing of human dopamine D2 receptor are associated with cocaine abuseRobert A Moyer, Danxin Wang, Audrey C Papp, et al.
Neuropharmacology|August 26, 2015
Noribogaine is a G-protein biased κ-opioid receptor agonistEmeline L Maillet, Nicolas Milon, Mari D Heghinian, et al.
Pageof 15